Anticoagulation in Patients With Atrial Fibrillation. Underuse of Warfarin Is Multifactorial.

BMJ
doi 10.1136/bmj.307.6917.1492-a
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Warfarin Anticoagulation in Hemodialysis Patients With Atrial Fibrillation: Comparison of Nephrologist-Led and Anticoagulation Clinic-Led Management

BMC Nephrology
Nephrology
2018English

Prediction of Unstable Anticoagulation With Acenocoumarol Versus Warfarin in Atrial Fibrillation

Cardiology Journal
MedicineCardiovascular MedicineCardiology
2017English

Underuse of Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation in Italy

Internal and Emergency Medicine
Internal MedicineEmergency Medicine
2007English

PCV79 Compliance With Warfarin Therapy by Australian Patients With Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Warfarin Versus Warfarin and Aspirin in Atrial Fibrillation

Neurological Bulletin
2011English

Efficacy and Safety of Oral Anticoagulation in Elderly Patients With Atrial Fibrillation

Anatolian journal of cardiology
Cardiovascular MedicineCardiology
2018English

Persistence With Therapy Among Patients Treated With Warfarin for Atrial Fibrillation

Archives of Internal Medicine
2012English

Status of Bucolome Use and Warfarin Dose in Anticoagulation Therapy in Patients With Atrial Fibrillation--A Report From the J-Rhythm Registry--

Japanese Journal of Electrocardiology
2013English

Dabigatran Versus Warfarin in Patients With Atrial Fibrillation: An Analysis of Patients Undergoing Cardioversion

Circulation
Cardiovascular MedicinePhysiologyCardiology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy